Effects of bile salts on propranolol distribution into liposomes studied by capillary electrophoresis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 3, 2011, Pages 553-559

  Yang, Lin ^a   Tucker, Ian G ^a   Østergaard, Jesper ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Affinity capillary electrophoresis; Bile salt; Distribution coefficient; Frontal analysis; Liposome

Indexed keywords

BILE SALT; BUFFER; CHOLIC ACID; DEOXYCHOLIC ACID; LIPOSOME; MONOKETOCHOLIC ACID; PROPRANOLOL; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMICAL INTERACTION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); DRUG DISTRIBUTION; GEL MOBILITY SHIFT ASSAY; MEMBRANE BINDING; PARTICLE SIZE; PRIORITY JOURNAL; STATIC ELECTRICITY; ZETA POTENTIAL;

BILE ACIDS AND SALTS; BUFFERS; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MEMBRANE LIPIDS; PARTICLE SIZE; PROPRANOLOL;

EID: 79961128909     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.06.020     Document Type: Article

References (61)

1. Nicolazzo J.A., Charman S.A., Charman W.N. Methods to assess drug permeability across the blood-brain barrier. J. Pharm. Pharmacol. 2006, 58:281-293.
2. Garberg P., Ball M., Borg N., Cecchelli R., Fenart L., Hurst R.D., Lindmark T., Mabondzo A., Nilsson J.E., Raub T.J., Stanimirovic D., Terasaki T., Oberg J.O., Osterberg T. In vitro models for the blood-brain barrier. Toxicol. In Vitro 2005, 19:299-334.
3. Morimoto K., Nakai T., Morisaka K. Evaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in-vitro. J. Pharm. Pharmacol. 1987, 39:124-126.
4. Mikov M., Kevresan S., Kuhajda K., Jakovljevic V., Vasovic V. 3Alpha, 7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator. Pol. J. Pharmacol. 2004, 56:367-371.
5. Sakai M., Imai T., Ohtake H., Azuma H., Otagiri M. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J. Pharm. Sci. 1997, 86:779-785.
6. Sharma P., Varma M.V.S., Chawla H.P.S., Panchagnula R. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco 2005, 60:884-893.
7. Ross B.P, Braddy A.C., McGeary R.P., Blanchfield J.T., Prokai L., Toth I. Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery. Mol. Pharm. 2004, 1:233-245.
8. Zhao D., Hirst B.H. Bile salt-induced increases in duodenal brush-border membrane proton permeability, fluidity, and fragility. Dig. Dis. Sci. 1990, 35:589-595.
9. Sugawara M., Takekuma Y., Yamada H., Kobayashi M., Iseki K., Miyazaki K. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. J. Pharm. Sci. 1998, 87:960-965.
10. Schwarz M.A., Neubert R.H.H., Dongowski G. Characterization of interactions between bile salts and drugs by micellar electrokinetic capillary chromatography. Part I. Pharm. Res. 1996, 13:1174-1180.
11. Poša M., Guzsvány V., Csanádi J., Kevrešan S., Kuhajda K. Formation of hydrogen-bonded complexes between bile acids and lidocaine in the lidocaine transfer from an aqueous phase to chloroform. Eur. J. Pharm. Sci. 2008, 34:281-292.
12. Lee D.Y., Lee J., Lee S., Kim S.K., Byun Y. Liphophilic complexation of heparin based on bile acid for oral delivery. J. Control. Release 2007, 123:39-45.
13. Chae H.W., Kim I.W., Jin H.E., Kim D.D., Chung S.J., Shim C.K. Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine. Arch. Pharm. Res. 2008, 31:103-110.
14. Song I.S., Han Y.H., Chung S.J., Shim C.K. Contribution of ion-pair complexation with bile salts to the transport of organic cations across LLC-PK1 cell monolayers. Pharm. Res. 2003, 20:597-604.
15. Van Balen G.P., Martinet C.A.M., Caron G., Bouchard G., Reist M., Carrupt P.M., Fruttero R., Gasco A., Testa B. Liposome/water lipophilicity: methods, information content, and pharmaceutical applications. Med. Res. Rev. 2004, 24:299-324.
16. Ottiger C., Wunderli-Allenspach H. Partition behaviour of acids and bases in a phosphatidylcholine liposome-buffer equilibrium dialysis system. Eur. J. Pharm. Sci. 1997, 5:223-231.
17. Barzanti C., Evans R., Fouquet J., Gouzin L., Howarth N.M., Kean G., Levet E., Wang D., Wayemberg E., Yeboah A.A., Kraft A. Potentiometric determination of octanol-water and liposome-water partition coefficients (logP) of ionizable organic compounds. Tetrahedron Lett. 2007, 48:3337-3341.
18. Fruttero R., Caron G., Fornatto E., Boschi D., Ermondi G., Gasco A., Carrupt P.A., Testa B. Mechanisms of liposomes/water partitioning of (p-methylbenzyl)alkylamines. Pharm. Res. 1998, 15:1407-1413.
19. Ferreira H., Lúcio M., Lima J.L.F.C., Matos C., Reis S. Interaction of clonixin with EPC liposomes used as membrane models. J. Pharm. Sci. 2005, 94:1277-1287.
20. Østergaard J., Heegaard N.H.H. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding. Electrophoresis 2003, 24:2903-2913.
21. Østergaard J., Heegaard N.H.H. Bioanalytical interaction studies executed by preincubation affinity capillary eletrophoresis. Electrophoresis 2006, 27:2590-2608.
22. Vuignier K., Schappler J., Veuthey J.L., Carrupt P.A., Martel S. Drug-protein binding: a critical review of analytical tools. Anal. Bioanal. Chem. 2010, 398:53-66.
23. Østergaard J., Jorgensen L., Thomsen A.E., Larsen S.W., Larsen C., Jensen H. Drug-liposome distribution phenomena studied by capillary electrophoresis-frontal analysis. Electrophoresis 2008, 29:3320-3324.
24. Kuroda Y., Watanabe Y., Shibukawa A., Nakagawa T. Role of phospholipids in drug-LDL bindings as studied by high-performance frontal analysis/capillary electrophoresis. J. Pharm. Biomed. Anal. 2003, 30:1869-1877.
25. Østergaard J., Moeller E.H. Ghrelin-liposome interactions: characterization of liposomal formulations of an acylated 28-amino acid peptide using CE. Electrophoresis 2010, 31:339-345.
26. Franzen U., Jorgensen L., Larsen C., Heegaard N.H.H., Østergaard J. Determination of liposome-buffer distribution coefficients of charged drugs by capillary electrophoresis frontal analysis. Electrophoresis 2009, 30:2711-2719.
27. Franzen U., Vermehren C., Jensen H., Østergaard J. Physicochemical characterization of a PEGylated liposomal drug formulation using capillary electrophoresis. Electrophoresis 2011, 32:738-748.
28. Yang L., Zhang H., Mikov M., Tucker I.G. Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer. Mol. Pharm. 2009, 6:448-456.
29. Liu X., Dahdouh F., Salgado M., Gomez F.A. Recent advances in affinity capillary electrophoresis (2007). J. Pharm. Sci. 2009, 98:394-410.
30. Heegaard N.H.H., Nilsson S., Guzman N.A. Affinity capillary electrophoresis: important application areas and some recent developments. J. Chromatogr. B 1998, 715:29-54.
31. Rundlett K.L., Armstrong D.W. Methods for the estimation of binding constants by capillary electrophoresis. Electrophoresis 1997, 18:2194-2202.
32. Tanaka Y., Terabe S. Estimation of binding constants by capillary electrophoresis. J. Chromatogr. B 2002, 768:81-92.
33. Heegaard N.H.H., Schou C., Østergaard J. Methods in Molecular Biology 2007, 303-338. Humana Press, Inc., Totowa, New Jersey. M. Zachariou (Ed.).
34. Stewart J.C.M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 1980, 104:10-14.
35. Newman G.C., Huang C.H. Structural studies on phosphatidylcholine-cholesterol mixed vesicles. Biochemistry (Mosc.) 1975, 14:3363-3370.
36. Johnson S.M., Buttress N. The osmotic insensitivity of sonicated liposomes and the density of phospholipid-cholesterol mixtures. Biochim. Biophys. Acta: Biomembr. 1973, 307:20-26.
37. Alan Stuart K.O. Kendall's Advanced Theory of Statistics 1998, Wiley, London. 6th ed.
38. Vespalec R., Boček P. Calculation of stability constants for the chiral selector-enantiomer interactions from electrophoretic mobilities. J. Chromatogr. A 2000, 875:431-445.
39. Ušelová-Včeláková K., Zusková I., Gaš B. Stability constants of amino acids, peptides, proteins, and other biomolecules determined by CE and related methods: recapitulation of published data. Electrophoresis 2007, 28:2145-2152.
40. Østergaard J., Jensen H., Holm R. Use of correction factors in mobility shift affinity capillary electrophoresis for weak analyte-ligand interactions. J. Sep. Sci. 2009, 32:1712-1721.
41. Østergaard J., Hansen S.H., Jensen H., Thomsen A.E. Pre-equilibrium capillary zone electrophoresis or frontal analysis: advantages of plateau peak conditions in affinity capillary electrophoresis. Electrophoresis 2005, 26:4050-4054.
42. Hasanovic A., Hollick C., Fischinger K., Valenta C. Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers. Eur. J. Pharm. Biopharm. 2010, 75:148-153.
43. Biruss B., Valenta C. Comparative characterization of the physicochemical behavior and skin permeation of extruded DPPC liposomes modified by selected additives. J. Pharm. Sci. 2007, 96:2171-2176.
44. Roda A., Fini A. Effect of nuclear hydroxy substituents on aqueous solubility and acidic strength of bile acids. Hepatology 1984, 4:72S-76S.
45. Hofmann A.F., Roda A. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J. Lipid Res. 1984, 25:1477-1489.
46. Cabral D.J., Hamilton J.A., Small D.M. The ionization behavior of bile acids in different aqueous environments. J. Lipid Res. 1986, 27:334-343.
47. Kokkona M., Kallinteri P., Fatouros D., Antimisiaris S.G. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur. J. Pharm. Sci. 2000, 9:245-252.
48. Richards M.H., Gardner C.R. Effects of bile salts on the structural integrity of liposomes. Biochim. Biophys. Acta 1978, 543:508-522.
49. Schwarz M.A., Neubert R.H.H., Ruttinger H.H. Application of capillary electrophoresis for characterizing interactions between drugs and bile salts. Part I. J. Chromatogr. A 1996, 745:135-143.
50. Schwarz M.A., Raith K., Ruttinger H.H., Dongowski G., Neubert R.H.H. Investigation of the interactions between drugs and mixed bile salt/lecithin micelles. A characterization by micellar affinity capillary electrophoresis (MACE). Part III. J. Chromatogr. A 1997, 781:377-389.
51. Shim C.K., Nishigaki R., Iga T., Hanano M. Determination of extraction constant, true partition coefficient and formation constant of ion-pair complexes of quaternary ammonium salts, tetrabutylammonium bromide and isopropamide iodide, with some organic anions by a solvent extraction technique. Int. J. Pharm. 1981, 8:143-151.
52. Oakenfull D., Fenwick D. Hydrophobic interaction between the bile acids and long-chain alkyltrimethylammonium ions: a model for cholesterol-lipid interaction. Aust. J. Chem. 1977, 30:335-344.
53. Connors K.A. Binding Constants: The Measurement of Molecular Complex Stability 1987, John Wiley & Sons, New York.
54. Bowser M.T., Chen D.D.Y. Monte Carlo simulation of error propagation in the determination of binding constants from rectangular hyperbolae. 1. Ligand concentration range and binding constant. J. Phys. Chem. A 1998, 102:8063-8071.
55. Deranleau D.A. Theory of the measurement of weak molecular complexes. I. General considerations. J. Am. Chem. Soc. 1969, 91:4044-4049.
56. Stahl P.H. Pharmaceutical Salts: Properties, Selection and Use 2008, Wiley-VCH, Zurick.
57. Ma H., Luo M., Shao S., Liu X., Jiang S. Hydrogen-bond effection-pair association in the separation of neutral calixpyrroles by nonaqueous capillary electrophoresis. J. Chromatogr. A 2008, 1188:57-60.
58. Gasco M.R., Trotta M., Eandi M. The influence of bile salts on the absorption in vitro and in vivo of propranolol. J. Pharm. Biomed. Anal. 1984, 2:425-439.
59. Lee H.K., Chien Y.W., Lin T.K., Lambert H.J. Functional group contribution of bile salt molecules to partitioning of a quaternary ammonium N,N-dimethyl derivative of propranolol. J. Pharm. Sci. 1978, 67:847-849.
60. Chantres J.R., Elorza B., Elorza M.A., Rodado P. Deoxycholate alters the order of acyl chains in freeze-thaw extrusion vesicles of L-[alpha]-dipalmitoyl phosphatidylcholine: study of the 1,6-diphenyl-1,3,5-hexatriene steady-state fluorescence anisotropy. Int. J. Pharm. 1996, 138:139-148.
61. Nussio M., Sykes M., Miners J., Shapter J. Characterisation of the binding of cationic amphiphilic drugs to phospholipid bilayers using surface plasmon resonance. ChemMedChem 2007, 2:366-373.